Cardio Diagnostics amends SPA with Yorkville, extends second closing to Sept 15, 2023

Cardio Diagnostics Holdings, Inc.

Amendment delays second closing of $6.2M convertible debenture from prior date to September 15, 2023.
Purchase price remains $5.58M (90% of principal); conditions per SPA Sections 6 and 7 must be met.
No other changes to the securities purchase agreement or the first $5M debenture terms.
Yorkville is a fund managed by Yorkville Advisors Global, LP.

Key facts

Extracted from this filing and checked against the source text.

Material Agreements SEC 8-K Item 1.01/1.02 confidence 0.95

Cardio Diagnostics Holdings, Inc. amended Amendment to Securities Purchase Agreement with YA II PN, Ltd. (Yorkville) valued at Second Closing date extended to September 15, 2023, with conditions (effective 2023-06-02).

Action: amendment
Agreement: credit facility
Counterparty: YA II PN, Ltd. (Yorkville)
Value: Second Closing date extended to September 15, 2023, with conditions
Effective: 2023-06-02

Exact text from the filing

By letter agreement dated June 2, 2023 (the “Amendment”), the Company and Yorkville mutually agreed that the date of the Second Closing will be September 15, 2023 (or such other date that is mutually agreed upon by the Company and Yorkville), provided that as of such date, the conditions to the Second Closing as set forth in Sections 6 and 7 of the Securities Purchase Agreement have been satisfied or waived.

View on SEC.gov

Browse all material agreements →

Cardio Diagnostics Holdings, Inc. filing history →

Source: SEC EDGAR

accession 0001079973-23-000822

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.